OP0130 Mepolizumab for the Treatment of Patients With Eosinophilic Granulomatosis With Polyangiitis: A Phase Iii Randomised, Placebo-Controlled Trial
doi 10.1136/annrheumdis-2017-eular.5610
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2017
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism